Global Non-Invasive Prenatal Screening (NIPS) Market Research Report 2024(Status and Outlook)

Global Non-Invasive Prenatal Screening (NIPS) Market Research Report 2024(Status and Outlook)



Report Overview: The Global Non-Invasive Prenatal Screening (NIPS) Market Size was estimated at USD 4175.01 million in 2023 and is projected to reach USD 7236.36 million by 2029, exhibiting a CAGR of 9.60% during the forecast period. This report provides a deep insight into the global Non-Invasive Prenatal Screening (NIPS) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Non-Invasive Prenatal Screening (NIPS) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market. In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Non-Invasive Prenatal Screening (NIPS) market in any manner. Global Non-Invasive Prenatal Screening (NIPS) Market: Market Segmentation Analysis The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments. Key Company Myriad Genetics Illumina Progenity Natera Yourgene Health Roche Sequencing Solutions (RSS) Eurofins LifeCodexx GmbH Labcorp PerkinElmer Harmony Market Segmentation (by Type) Trisomy 21 Trisomy 18 Trisomy 13 Sex Chromosome Aneuploidies Others Market Segmentation (by Application) Hospital Clinic Geographic Segmentation • North America (USA, Canada, Mexico) • Europe (Germany, UK, France, Russia, Italy, Rest of Europe) • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific) • South America (Brazil, Argentina, Columbia, Rest of South America) • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA) Key Benefits of This Market Research: • Industry drivers, restraints, and opportunities covered in the study • Neutral perspective on the market performance • Recent industry trends and developments • Competitive landscape & strategies of key players • Potential & niche segments and regions exhibiting promising growth covered • Historical, current, and projected market size, in terms of value • In-depth analysis of the Non-Invasive Prenatal Screening (NIPS) Market • Overview of the regional outlook of the Non-Invasive Prenatal Screening (NIPS) Market: Key Reasons to Buy this Report: • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change • This enables you to anticipate market changes to remain ahead of your competitors • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly • Provision of market value (USD Billion) data for each segment and sub-segment • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis • Provides insight into the market through Value Chain • Market dynamics scenario, along with growth opportunities of the market in the years to come • 6-month post-sales analyst support Customization of the Report In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met. Note: this report may need to undergo a final check or review and this could take about 48 hours. Chapter Outline Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods. Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Non-Invasive Prenatal Screening (NIPS) Market and its likely evolution in the short to mid-term, and long term. Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market. Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis. Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc. Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years. Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years. Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Non-Invasive Prenatal Screening (NIPS)
1.2 Key Market Segments
1.2.1 Non-Invasive Prenatal Screening (NIPS) Segment by Type
1.2.2 Non-Invasive Prenatal Screening (NIPS) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Non-Invasive Prenatal Screening (NIPS) Market Overview
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Non-Invasive Prenatal Screening (NIPS) Market Competitive Landscape
3.1 Global Non-Invasive Prenatal Screening (NIPS) Revenue Market Share by Company (2019-2024)
3.2 Non-Invasive Prenatal Screening (NIPS) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Non-Invasive Prenatal Screening (NIPS) Market Size Sites, Area Served, Product Type
3.4 Non-Invasive Prenatal Screening (NIPS) Market Competitive Situation and Trends
3.4.1 Non-Invasive Prenatal Screening (NIPS) Market Concentration Rate
3.4.2 Global 5 and 10 Largest Non-Invasive Prenatal Screening (NIPS) Players Market Share by Revenue
3.4.3 Mergers & Acquisitions, Expansion
4 Non-Invasive Prenatal Screening (NIPS) Value Chain Analysis
4.1 Non-Invasive Prenatal Screening (NIPS) Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 The Development and Dynamics of Non-Invasive Prenatal Screening (NIPS) Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 Mergers & Acquisitions
5.5.2 Expansions
5.5.3 Collaboration/Supply Contracts
5.6 Industry Policies
6 Non-Invasive Prenatal Screening (NIPS) Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Type (2019-2024)
6.3 Global Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate by Type (2019-2024)
7 Non-Invasive Prenatal Screening (NIPS) Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Non-Invasive Prenatal Screening (NIPS) Market Size (M USD) by Application (2019-2024)
7.3 Global Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate by Application (2019-2024)
8 Non-Invasive Prenatal Screening (NIPS) Market Segmentation by Region
8.1 Global Non-Invasive Prenatal Screening (NIPS) Market Size by Region
8.1.1 Global Non-Invasive Prenatal Screening (NIPS) Market Size by Region
8.1.2 Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Region
8.2 North America
8.2.1 North America Non-Invasive Prenatal Screening (NIPS) Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Non-Invasive Prenatal Screening (NIPS) Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Non-Invasive Prenatal Screening (NIPS) Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Non-Invasive Prenatal Screening (NIPS) Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Myriad Genetics
9.1.1 Myriad Genetics Non-Invasive Prenatal Screening (NIPS) Basic Information
9.1.2 Myriad Genetics Non-Invasive Prenatal Screening (NIPS) Product Overview
9.1.3 Myriad Genetics Non-Invasive Prenatal Screening (NIPS) Product Market Performance
9.1.4 Myriad Genetics Non-Invasive Prenatal Screening (NIPS) SWOT Analysis
9.1.5 Myriad Genetics Business Overview
9.1.6 Myriad Genetics Recent Developments
9.2 Illumina
9.2.1 Illumina Non-Invasive Prenatal Screening (NIPS) Basic Information
9.2.2 Illumina Non-Invasive Prenatal Screening (NIPS) Product Overview
9.2.3 Illumina Non-Invasive Prenatal Screening (NIPS) Product Market Performance
9.2.4 Myriad Genetics Non-Invasive Prenatal Screening (NIPS) SWOT Analysis
9.2.5 Illumina Business Overview
9.2.6 Illumina Recent Developments
9.3 Progenity
9.3.1 Progenity Non-Invasive Prenatal Screening (NIPS) Basic Information
9.3.2 Progenity Non-Invasive Prenatal Screening (NIPS) Product Overview
9.3.3 Progenity Non-Invasive Prenatal Screening (NIPS) Product Market Performance
9.3.4 Myriad Genetics Non-Invasive Prenatal Screening (NIPS) SWOT Analysis
9.3.5 Progenity Business Overview
9.3.6 Progenity Recent Developments
9.4 Natera
9.4.1 Natera Non-Invasive Prenatal Screening (NIPS) Basic Information
9.4.2 Natera Non-Invasive Prenatal Screening (NIPS) Product Overview
9.4.3 Natera Non-Invasive Prenatal Screening (NIPS) Product Market Performance
9.4.4 Natera Business Overview
9.4.5 Natera Recent Developments
9.5 Yourgene Health
9.5.1 Yourgene Health Non-Invasive Prenatal Screening (NIPS) Basic Information
9.5.2 Yourgene Health Non-Invasive Prenatal Screening (NIPS) Product Overview
9.5.3 Yourgene Health Non-Invasive Prenatal Screening (NIPS) Product Market Performance
9.5.4 Yourgene Health Business Overview
9.5.5 Yourgene Health Recent Developments
9.6 Roche Sequencing Solutions (RSS)
9.6.1 Roche Sequencing Solutions (RSS) Non-Invasive Prenatal Screening (NIPS) Basic Information
9.6.2 Roche Sequencing Solutions (RSS) Non-Invasive Prenatal Screening (NIPS) Product Overview
9.6.3 Roche Sequencing Solutions (RSS) Non-Invasive Prenatal Screening (NIPS) Product Market Performance
9.6.4 Roche Sequencing Solutions (RSS) Business Overview
9.6.5 Roche Sequencing Solutions (RSS) Recent Developments
9.7 Eurofins LifeCodexx GmbH
9.7.1 Eurofins LifeCodexx GmbH Non-Invasive Prenatal Screening (NIPS) Basic Information
9.7.2 Eurofins LifeCodexx GmbH Non-Invasive Prenatal Screening (NIPS) Product Overview
9.7.3 Eurofins LifeCodexx GmbH Non-Invasive Prenatal Screening (NIPS) Product Market Performance
9.7.4 Eurofins LifeCodexx GmbH Business Overview
9.7.5 Eurofins LifeCodexx GmbH Recent Developments
9.8 Labcorp
9.8.1 Labcorp Non-Invasive Prenatal Screening (NIPS) Basic Information
9.8.2 Labcorp Non-Invasive Prenatal Screening (NIPS) Product Overview
9.8.3 Labcorp Non-Invasive Prenatal Screening (NIPS) Product Market Performance
9.8.4 Labcorp Business Overview
9.8.5 Labcorp Recent Developments
9.9 PerkinElmer
9.9.1 PerkinElmer Non-Invasive Prenatal Screening (NIPS) Basic Information
9.9.2 PerkinElmer Non-Invasive Prenatal Screening (NIPS) Product Overview
9.9.3 PerkinElmer Non-Invasive Prenatal Screening (NIPS) Product Market Performance
9.9.4 PerkinElmer Business Overview
9.9.5 PerkinElmer Recent Developments
9.10 Harmony
9.10.1 Harmony Non-Invasive Prenatal Screening (NIPS) Basic Information
9.10.2 Harmony Non-Invasive Prenatal Screening (NIPS) Product Overview
9.10.3 Harmony Non-Invasive Prenatal Screening (NIPS) Product Market Performance
9.10.4 Harmony Business Overview
9.10.5 Harmony Recent Developments
10 Non-Invasive Prenatal Screening (NIPS) Regional Market Forecast
10.1 Global Non-Invasive Prenatal Screening (NIPS) Market Size Forecast
10.2 Global Non-Invasive Prenatal Screening (NIPS) Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Country
10.2.3 Asia Pacific Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Region
10.2.4 South America Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Non-Invasive Prenatal Screening (NIPS) by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Non-Invasive Prenatal Screening (NIPS) Market Forecast by Type (2025-2030)
11.2 Global Non-Invasive Prenatal Screening (NIPS) Market Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings